Alefacept in the treatment of hyperkeratotic palmoplantar psoriasis

Dermatologic Therapy

Volumn 23, Issue 5, 2010, Pages 556-560

  Lior, Sagi ^a   Grigory, Kriger ^a   Pnina, Shemesh ^b   Joseph, Shiri ^b   Felix, Pavlotsky ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b Tel Nordau Medical Center   (Israel)

Author keywords

alefacept; palmoplantar psoriasis

Indexed keywords

ALEFACEPT; ETRETIN; METHOTREXATE; DERMATOLOGICAL AGENT; HYBRID PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG DOSE REDUCTION; DRUG TREATMENT FAILURE; FEMALE; HUMAN; HYPERKERATOSIS; MALE; PAIN ASSESSMENT; PHYSICAL EXAMINATION; PRURITUS; PSORIASIS; PUSTULOSIS PALMOPLANTARIS; TREATMENT RESPONSE; KERATOSIS; MIDDLE AGED; TREATMENT OUTCOME;

ADULT; AGED; DERMATOLOGIC AGENTS; FEMALE; HUMANS; KERATOSIS; MALE; MIDDLE AGED; PSORIASIS; RECOMBINANT FUSION PROTEINS; TREATMENT OUTCOME;

EID: 77957301366     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/j.1529-8019.2010.01361.x     Document Type: Article

References (50)

1. Farber EM, Nall ML. The natural history of psoriasis in 5600 patients. Dermatologica 1974 : 148 : 1 18.
2. Kumar B, Saraswat A, Kaur I. Palmoplantar lesions in psoriasis: a study of 3065 patients. Acta Derm Venereol 2002 : 82 : 192 195.
3. Pettey AA, Balkrishnan R, Rapp SR, et al. Patients with palmoplantar psoriasis have more physical disability and discomfort than patients with other forms of psoriasis: implications for clinical practice. J Am Acad Dermatol 2003 : 49 : 271 275.
4. Griffiths CE, Christophers E, Barker JN, et al. A classification of psoriasis vulgaris according to phenotype. Br J Dermatol 2007 : 156 : 258 262.
5. Cather JC, Menter A. Combining traditional agents and biologics for the treatment of psoriasis. Semin Cutan Med Surg 2005 : 24 : 37 45.
6. Hellgren L, Mobacken H. Pustulosis palmaris et plantaris. Prevalence, clinical observations and prognosis. Acta Derm Venereol 1971 : 51 : 284 288.
7. Marsland AM, Chalmers RJ, Hollis S, et al. Interventions for chronic palmoplantar pustulosis. Cochrane Database Syst Rev 2006 : CD001433.
8. Gomez Vazquez M, Fernandez-Redondo V, Toribio J. Corticosteroid iatrogenesis in a patient with palmoplantar psoriasis. J Eur Acad Dermatol Venereol 2004 : 18 : 370 371.
9. Adisen E, Tekin O, Gulekon A, et al. A retrospective analysis of treatment responses of palmoplantar psoriasis in 114 patients. J Eur Acad Dermatol Venereol 2009 : 23 : 814 819.
10. Kumar B, Kumar R, Kaur I. Coal tar therapy in palmoplantar psoriasis: old wine in an old bottle? Int J Dermatol 1997 : 36 : 309 312.
11. Duweb GA, Abuzariba O, Rahim M, et al. Occlusive versus nonocclusive calcipotriol ointment treatment for palmoplantar psoriasis. Int J Tissue React 2001 : 23 : 59 62.
12. Egawa K. Topical vitamin D3 derivatives in treating hyperkeratotic palmoplantar eczema: a report of five patients. J Dermatol 2005 : 32 : 381 386.
13. Kumar B, Sandhu K, Kaur I. Topical 0.25% methotrexate gel in a hydrogel base for palmoplantar psoriasis. J Dermatol 2004 : 31 : 798 801.
14. Behrens S, von Kobyletzki G, Gruss C, et al. PUVA-bath photochemotherapy (PUVA-soak therapy) of recalcitrant dermatoses of the palms and soles. Photodermatol Photoimmunol Photomed 1999 : 15 : 47 51. (Pubitemid 29173203)
15. Bruynzeel DP, Boonk WJ. PUVA therapy of chronic dermatoses on the palms and soles. Z Hautkr 1980 : 55 : 523 529.
16. Calzavara-Pinton PG, Ortel B, Honigsmann H, et al. Safety and effectiveness of an aggressive and individualized bath-PUVA regimen in the treatment of psoriasis. Dermatology 1994 : 189 : 256 259.
17. Coleman WR, Lowe NJ, David M, et al. Palmoplantar psoriasis: experience with 8-methoxypsoralen soaks plus ultraviolet A with the use of a high-output metal halide device. J Am Acad Dermatol 1989 : 20 : 1078 1082.
18. Hannuksela M, Karvonen J. Trioxsalen bath plus UVA effective and safe in the treatment of psoriasis. Br J Dermatol 1978 : 99 : 703 707.
19. Hawk JL, Grice PL. The efficacy of localized PUVA therapy for chronic hand and foot dermatoses. Clin Exp Dermatol 1994 : 19 : 479 482.
20. Mobacken H, Rosen K, Swanbeck G. Oral psoralen photochemotherapy (PUVA) of hyperkeratotic dermatitis of the palms. Br J Dermatol 1983 : 109 : 205 208.
21. Morison WL, Parrish JA, Fitzpatrick TB. Oral methoxsalen photochemotherapy of recalcitrant dermatoses of the palms and soles. Br J Dermatol 1978 : 99 : 293 302.
22. Roenigk HH, Jr., Martin JS. Photochemotherapy for psoriasis. Arch Dermatol 1977 : 113 : 1667 1670.
23. Rosen K. Pustulosis palmoplantaris and chronic eczematous hand dermatitis. Treatment, epidermal Langerhans cells and association with thyroid disease. Acta Derm Venereol Suppl (Stockh) 1988 : 137 : 1 52.
24. Salo OP, Lassus A, Taskinen J. Trioxsalen bath plus UVA treatment of psoriasis. Plasma concentration of the drug and clinical results. Acta Derm Venereol 1981 : 61 : 551 554.
25. Vaatainen N, Hannuksela M, Karvonen J. Long-term local trioxsalen photochemotherapy in psoriasis. Dermatologica 1981 : 163 : 229 231.
26. Nordal EJ, Christensen OB. Treatment of chronic hand dermatoses with UVB-TL01. Acta Derm Venereol 2004 : 84 : 302 304.
27. Sezer E, Erbil AH, Kurumlu Z, et al. Comparison of the efficacy of local narrowband ultraviolet B (NB-UVB) phototherapy versus psoralen plus ultraviolet A (PUVA) paint for palmoplantar psoriasis. J Dermatol 2007 : 34 : 435 440.
28. Neumann NJ, Mahnke N, Korpusik D, et al. Treatment of palmoplantar psoriasis with monochromatic excimer light (308-nm) versus cream PUVA. Acta Derm Venereol 2006 : 86 : 22 24.
29. Nistico SP, Saraceno R, Stefanescu S, et al. A 308-nm monochromatic excimer light in the treatment of palmoplantar psoriasis. J Eur Acad Dermatol Venereol 2006 : 20 : 523 526.
30. Lawrence CM, Marks J, Parker S, et al. A comparison of PUVA-etretinate and PUVA-placebo for palmoplantar pustular psoriasis. Br J Dermatol 1984 : 110 : 221 226.
31. Erkko P, Granlund H, Remitz A, et al. Double-blind placebo-controlled study of long-term low-dose cyclosporin in the treatment of palmoplantar pustulosis. Br J Dermatol 1998 : 139 : 997 1004.
32. Madhok R, Muller SA, Dicken CH. Treatment of psoriasis with etretin: a preliminary report. Mayo Clin Proc 1987 : 62 : 1084 1089.
33. Meinardi MM, de Rie MA, Bos JD. Oral cyclosporin A is effective in clearing persistent pustulosis palmaris et plantaris. Acta Derm Venereol 1990 : 70 : 77 79.
34. Reitamo S, Erkko P, Remitz A, et al. Cyclosporine in the treatment of palmoplantar pustulosis. A randomized, double-blind, placebo-controlled study. Arch Dermatol 1993 : 129 : 1273 1279.
35. Reitamo S, Puska P, Lassus A. Cyclosporin in the treatment of palmo-plantar pustulosis. Br J Dermatol 1989 : 120 : 857.
36. White SI, Puttick L, Marks JM. Low-dose etretinate in the maintenance of remission of palmoplantar pustular psoriasis. Br J Dermatol 1986 : 115 : 577 582.
37. Boker A, Kimball AB, Rolz-Cruz G. Biologicals in the treatment of psoriasis. Curr Opin Investig Drugs 2007 : 8 : 939 946.
38. Bissonnette R, Poulin Y, Bolduc C, et al. Etanercept in the treatment of palmoplantar pustulosis. J Drugs Dermatol 2008 : 7 : 940 946.
39. Weinberg JM. Successful treatment of recalcitrant palmoplantar psoriasis with etanercept. Cutis 2003 : 72 : 396 398.
40. Ahmad K, Rogers S. Three years' experience with infliximab in recalcitrant psoriasis. Clin Exp Dermatol 2006 : 31 : 630 633.
41. Yawalkar N, Hunger RE. Successful treatment of recalcitrant palmoplantar pustular psoriasis with sequential use of infliximab and adalimumab. Dermatology 2009 : 218 : 79 83.
42. Ghate JV, Alspaugh CD. Adalimumab in the management of palmoplantar psoriasis. J Drugs Dermatol 2009 : 8 : 1136 1139.
43. Roux CH, Brocq O, Leccia N, et al. New-onset psoriatic palmoplantaris pustulosis following infliximab therapy: a class effect? J Rheumatol 2007 : 34 : 434 437.
44. Bell HK, Parslew RA. Use of basiliximab as a cyclosporin-sparing agent in palmoplantar pustular psoriasis with myalgia as an adverse effect. Br J Dermatol 2002 : 147 : 606 607.
45. Melwani PM, Penate Y, Guillermo N, et al. Leflunomide in the treatment of palmoplantar pustulosis. Arch Dermatol 2009 : 145 : 1224 1226.
46. Fretzin S, Crowley J, Jones L, et al. Successful treatment of hand and foot psoriasis with efalizumab therapy. J Drugs Dermatol 2006 : 5 : 838 846.
47. Carr D, Tusa MG, Carroll CL, et al. Open label trial of alefacept in palmoplantar pustular psoriasis. J Dermatolog Treat 2008 : 19 : 97 100.
48. Guenther LC. Alefacept is safe and efficacious in the treatment of palmar plantar pustulosis. J Cutan Med Surg 2007 : 11 : 202 205.
49. Prossick TA, Belsito DV. Alefacept in the treatment of recalcitrant palmoplantar and erythrodermic psoriasis. Cutis 2006 : 78 : 178 180.
50. Myers W, Christiansen L, Gottlieb AB. Treatment of palmoplantar psoriasis with intramuscular alefacept. J Am Acad Dermatol 2005 : 53 : S127 S129.